(Q35687482)

9 August 2017

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease (English)

1 reference

9 August 2017

0 references

1 reference

9

Atsushi Imai

1 reference

9 August 2017

Shingo Hatakeyama

1

1 reference

9 August 2017

Hayato Yamamoto

2

1 reference

9 August 2017

Akiko Okamoto

3

1 reference

9 August 2017

Kengo Imanishi

4

1 reference

9 August 2017

Noriko Tokui

5

1 reference

9 August 2017

Teppei Okamoto

6

1 reference

9 August 2017

Yuichiro Suzuki

7

1 reference

9 August 2017

Naoaki Sugiyama

8

1 reference

9 August 2017

Shigemasa Kudo

10

1 reference

9 August 2017

Takahiro Yoneyama

11

1 reference

9 August 2017

Yasuhiro Hashimoto

12

1 reference

9 August 2017

Takuya Koie

13

1 reference

9 August 2017

Noritaka Kaminura

14

1 reference

9 August 2017

Hisao Saitoh

15

1 reference

9 August 2017

Tomihisa Funyu

16

1 reference

9 August 2017

Chikara Ohyama

17

1 reference

9 August 2017

12 January 2012

1 reference

International Journal of Nephrology

9 August 2017

1 reference

9 August 2017

2012

1 reference

9 August 2017

376128

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Revised equations for estimated GFR from serum creatinine in Japan

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Prediction equations to estimate glomerular filtration rate: an update

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263620

25 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F376128

Prospective Randomized Study Evaluating the Efficacy of the Spherical Adsorptive Carbon AST-120 in Chronic Kidney Disease Patients with Moderate Decrease in Renal Function

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F376128

AST-120 for preventing progression of chronic kidney disease: What can we conclude from the available evidence?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F376128

AST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysis

21 January 2018

1 reference

12 December 2020

AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases

1 reference

12 December 2020

[Clinical guideline review: Standards for initiation of chronic dialysis]

1 reference

12 December 2020

[Effect of an oral sorbent (AST-120) on the clinical course of uremic peak 2a in chronic renal failure]

1 reference

12 December 2020

Effects of oral adsorbent on experimental uremic rats

1 reference

12 December 2020

Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/376128

1 reference

9 August 2017

1 reference

9 August 2017

1 reference